Clinical considerations of lipid target and goal in dyslipidemia control

Clinical considerations of lipid target and goal in dyslipidemia control

Bibliographic Details
Main Authors:	Na-Qiong Wu, Jian-Jun Li
Format:	Article
Language:	English
Published:	Wiley 2016-03-01
Series:	Chronic Diseases and Translational Medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2095882X16300275

Similar Items

Six years’ experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias
by: Jacqueline S. Dron, et al.
Published: (2020-02-01)

LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias[S]
by: Christopher T. Johansen, et al.
Published: (2014-04-01)

ANALYSIS OF THE INTERACTION OF LIPID METABOLISM ALLELES IN DYSLIPIDEMIA
by: I. V. Nikolaev, et al.
Published: (2015-01-01)

Lipid-Lowering Nutraceuticals for an Integrative Approach to Dyslipidemia
by: Brian Cheung, et al.
Published: (2023-05-01)

Dietary Lipids and Dyslipidemia in Chronic Kidney Disease
by: Zdzislaw Kochan, et al.
Published: (2021-09-01)

Lipid goal attainment in diabetes mellitus patients after acute coronary syndrome: a subanalysis of Dyslipidemia International Study II-China
by: Tongshuai Guo, et al.
Published: (2023-07-01)

Real-World Evidence Evaluation on the Lipid Profile, Therapeutic Goals, and Safety of the Fixed-Dose Combination of Rosuvastatin/Ezetimibe (Trezete®) in Dyslipidemia Patients
by: Joel Rodríguez-Saldaña, et al.
Published: (2022-01-01)

The Effect of BMI on Blood Lipids and Dyslipidemia in Lactating Women
by: Lianlong Yu, et al.
Published: (2022-12-01)

HIGHER EDUCATION : GOALS AND CONSIDERATIONS /
by: Alvarado, Ronan, author
Published: (2018)

Aiming at a Moving Target: Theoretical and Methodological Considerations in the Study of Intraindividual Goal Conflict between Personal Goals
by: Julia Gorges, et al.
Published: (2017-11-01)

Dyslipidemia in subclinical hypothyroidism and the effect of thyroxine on lipid profile
by: Ajay Asranna, et al.
Published: (2012-01-01)

Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib
by: Miyares MA, et al.
Published: (2012-08-01)

Relationship between Dietary Habits and Control of Lipid Profiles in Patients with Dyslipidemia Using Pravastatin
by: Seo Young Kang, et al.
Published: (2021-10-01)

Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea.
by: Siin Kim, et al.
Published: (2020-01-01)

The relationship between payer type and lipid outcomes in response to clinical lifestyle interventions in youth with dyslipidemia
by: Jacob C. Hartz, et al.
Published: (2019-07-01)

Prevalence of Dyslipidemia in Pregnancy and Early Predictive Value of Blood Lipid Levels
by: YUAN Xianxian, LI Jing, WANG Jia, ZHANG Kexin, YANG Ruihua, ZHENG Wei, LI Guanghui
Published: (2024-02-01)

Suboptimal lipid levels in clinical practice among Portuguese adults with dyslipidemia under lipid-lowering therapy: Data from the DISGEN-LIPID study
by: Pedro Marques da Silva, et al.
Published: (2019-08-01)

Effect of crude-herb moxibustion on blood lipids in rats with dyslipidemia
by: Lian Duan, et al.
Published: (2014-10-01)

Clinician Responses to Pediatric Lipid Screens Suggestive of Severe Dyslipidemia
by: Amy W. Zawacki, MD, et al.
Published: (2020-01-01)

TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis
by: Daniel Zysset, et al.
Published: (2016-10-01)

ABNORMAL BLOOD LIPIDS LEVELS (DYSLIPIDEMIA) TREATMENT WITH ACUPUNCTURE METHOD
by: Anissa Maulina Rinjani, et al.
Published: (2022-03-01)

Contemporary management and attainment of cholesterol targets for patients with dyslipidemia in China.
by: Fei Gao, et al.
Published: (2013-01-01)

PCSK9 and its clinical importance with the new therapeutic targets against dyslipidemia
by: Carlos Eduardo dos Santos Ferreira, et al.

A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation
by: Feiqiong Gao, et al.
Published: (2023-08-01)

Novel therapeutic targets and agents for pediatric dyslipidemia
by: Bhuvana Sunil, et al.
Published: (2021-11-01)

Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy
by: Xiaowei Yan, et al.
Published: (2019-01-01)

Lipid Profiles and Prevalence of Dyslipidemia in Eastern Iranian Adolescents, Birjand, 2012
by: Fatemeh Taheri, et al.
Published: (2015-07-01)

Lipid-Lowering and Antioxidant Functions of Bottle Gourd () Extract in Human Dyslipidemia
by: Charu Katare PhD, et al.
Published: (2014-04-01)

Effects of a yoga intervention on lipid profiles of diabetes patients with dyslipidemia
by: Nisha Shantakumari, et al.
Published: (2013-03-01)

Lipid profile and dyslipidemia among school-age children in urban Ghana
by: Anna Lartey, et al.
Published: (2018-03-01)

Effect of Unripe Berlin Banana Flour on Lipid Profile of Dyslipidemia Rats
by: Firda Agustin, et al.
Published: (2019-06-01)

Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
by: Klaus G. Parhofer
Published: (2015-10-01)

Clinical trials of lipid-modifying agents: design considerations
by: Bowman, L, et al.
Published: (2011)

Utility of single-pill amlodipine besylate/atorvastatin calcium to help Asian patients with hypertension and dyslipidemia achieve blood pressure and lipid goals: Results of a pooled analysis
by: Tse, H, et al.
Published: (2007)

Sustainability Goals in Economic Policy — Legal Considerations
by: Stefan Bechtold
Published: (2022-05-01)

Sustainability Goals in Economic Policy — Economic Considerations
by: Achim Wambach, et al.
Published: (2022-05-01)

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
by: Shuang Zhang, et al.
Published: (2022-05-01)

Prevalence and Clinical Characteristics of Dyslipidemia in Koreans
by: Jee-Sun Jeong, et al.
Published: (2017-03-01)

Is long-term PM1 exposure associated with blood lipids and dyslipidemias in a Chinese rural population?
by: Shuyuan Mao, et al.
Published: (2020-05-01)

Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia
by: Alwhaibi M, et al.
Published: (2019-12-01)